Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
15 March 2019
Closing Date:
24 April 2019
Location(s):
DE1 BADEN-WÜRTTEMBERG (DE Germany/DEUTSCHLAND)
Description:

The subject of the present call for tenders is the conclusion of contracts for the supply of radiologically active contractor practices in Baden-Württemberg with contrast agents within the scope of consultation hours for the period from 1.8.2019 to 30.9.2021. The contracting party undertakes to ensure the supply of the contract physicians in Baden-Württemberg with the contrast agents agreed by the tendered supply contracts ("contracts") and to grant the statutory health insurance funds a refund for each delivered, contractual medicinal product. 53 et seqq SGB X Reimbursement amounts agreed by the successful tenderer (s) applying to the supply of contrast agents prescribed by the client on the basis of existing or future consultancy needs agreement, 26 professional lots are formed as specified in Section II.2. Each or each of the ATC codes or ATC code subgroups named in the shelf lots forms its own shelf lot, tray lots without further subdivision are denoted by a letter, and a further subdivision of a tray is additionally indicated by a number (partial).


V08AA01 - amidotrizoic acid - partial 1

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

A total of 3 partial lots are formed for the active ingredient amidotrizoic acid. The medicinal products of the ATC Code contain different salts or combinations of different salts of the active substance, since otherwise the comparability would be more difficult.

Lot No. A1 relates to the partial lot 1. In this subject lot only contrast agents with the active ingredient amidotrizoic acid, which contain the salt L-lysine amidotrizoat, demand. The administration is carried out by oral and rectal administration.


V08AB04 - Iopamidol - partial 3

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

According to the different iodine concentrations, a total of three partial lots are formed for the active substance iopamidol.

Lot No. D3 concerns the partial lot 3. In this Fachos only contrast agents with the active substance Iopamidol and an iodine concentration of 370 mg / ml are in demand.


V08AB05 - Iopromide - partial 1

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

According to the different iodine concentrations, a total of two partial lots are formed for the active substance iopromide.

Lot No. E1 relates to the partial lot 1. In this subject lot only contrast agents with the active ingredient Iopromide and an iodine concentration of 300 mg / ml are in demand.


V08AB05 - Iopromide - partial 2

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

According to the different iodine concentrations, a total of two partial lots are formed for the active substance iopromide.

Lot No. E2 concerns Teillos 2. In this subject lot only contrast agents with the active ingredient Iopromide and an iodine concentration of 370 mg / ml are in demand.


V08AB07 - Ioversol

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

In this subject only contrast agents with the active ingredient ioversol and iodine concentrations of 240 mg / ml, 300 mg / ml, 320 mg / ml and 350 mg / ml are in demand.


V08AB09 - iodixanol

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

In this subject only contrast agents with the active ingredient iodixanol and iodine concentrations of 270 mg / ml and 320 mg / ml are in demand.


V08AB10 - Iomeprol

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

In this subject only contrast agents with the active ingredient Iomeprol and iodine concentrations of 150 mg / ml, 250 mg / ml, 300 mg / ml, 350 mg / ml and 400 mg / ml are in demand.


V08AB11 - Iobitridol

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

In this subject only contrast agents with the active ingredient Iobitridol and iodine concentrations of 300mg / ml and 350 mg / ml are in demand.


V08BA01 - Barium sulphate

Reference is made to the brief description of the subject of the contract (see point II.1.4).


V08CA01 - Gadopentetic acid

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

In this subject lot only contrast agents with the active ingredient gadopentetic acid and drug concentrations of 0.5 mmol / ml and 0.002 mmol / ml are in demand. The administration takes place by means of pre-filled syringe.


V08CA02 - Gadoteric acid - Partless 1

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

According to the different drug concentrations and dosage forms, a total of three partial lots are formed to the active ingredient gadoteric acid.

Lot No. L1 relates to the partial lot 1. In this subject Lot only contrast agents with the active ingredient gadoteric acid and a drug concentration of 0.5 mmol / ml are in demand. The administration takes place by means of pre-filled syringe.


V08AA01 - amidotrizoic acid - partial 2

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

A total of three partial lots are formed for the active ingredient amidotrizoic acid. The medicinal products of the ATC Code contain different salts or combinations of different salts of the active substance, since otherwise the comparability would be more difficult.

Lot No. A2 relates to the partial lot 2. In this subject lot only contrast agents with the active ingredient amidotrizoic acid, which contain the combination of the salts sodium amidotrizoat and L-lysine amidotrizoat, demand. The administration is carried out by oral and rectal administration.


V08CA02 - Gadoteric acid - Partless 2

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

According to the different drug concentrations and dosage forms, a total of three partial lots are formed to the active ingredient gadoteric acid.

Lot No. L2 relates to the partial lot 2. In this subject Lot only contrast agents with the active ingredient gadoteric acid and a drug concentration of 0.5 mmol / ml are in demand. The administration is carried out by means of a vial or injection bottle.


V08CA02 - Gadoteric acid - Partless 3

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

According to the different drug concentrations and dosage forms, a total of three partial lots are formed to the active ingredient gadoteric acid.

Lot No. L3 concerns Teillos 3. In this subject lot only contrast agents with the active ingredient gadoteric acid and a drug concentration of 0.0025 mmol / ml are in demand. The administration takes place by means of pre-filled syringe.


V08CA04 - Gadoteridol

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

In this subject only contrast agents with the active ingredient gadoteridol and an active ingredient concentration of 0.5 mmol / ml are in demand.


V08CA08 - gadobenic acid

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

In this subject only contrast agents with the active ingredient gadobenic acid and an active ingredient concentration of 0.5 mmol / ml are in demand.


V08CA09 - Gadobutrol

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

In this subject only contrast agents with the drug gadobutrol and an active ingredient concentration of 1 mmol / ml are in demand.


V08CA10 - Gadoxic acid

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

In this subject only contrast agents with the active ingredient Gadoxetsäure and an active ingredient concentration of 0.25 mmol / ml are in demand.


V08DA05 - sulfur hexafluoride

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

In this subject only contrast agents with the active ingredient sulfur hexafluoride and an active ingredient concentration of 0.045 mg / ml are in demand.


V08AA01 - amidotrizoic acid - partial 3

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

A total of three partial lots are formed for the active ingredient amidotrizoic acid. The medicinal products of the ATC Code contain different salts or combinations of different salts of the active substance, since otherwise the comparability would be more difficult.

Lot No. A3 relates to the partial lot 3. In this subject Lot only contrast agents with the active ingredient amidotrizoic acid, which contain the combination of the salts sodium amidotrizoat and meglumine amidotrizoat, demand. The administration is carried out by oral and rectal administration.


V08AA05 - ioxitalaminic acid

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

In this subject only contrast agents with the active ingredient ioxitalaminic acid and an iodine concentration of 300 mg / ml are in demand.

The areas of application Retrograde pyelography and micturition cystourethography (MCU) as well as computed tomography of the abdomen (especially esophagus, stomach, duodenum, ileus, subileus, large intestine) must be covered by the offer.


V08AB02 - iohexol - partless 1

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

According to the different iodine concentrations, a total of three partial lots are formed for the active substance iohexol.

Lot No. C1 relates to the partial lot 1. In this subject Lot only contrast agents with the active ingredient Iohexol and an iodine concentration of 240mg / ml are in demand.


V08AB02 - iohexol - partial 2

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

According to the different iodine concentrations, a total of three partial lots are formed for the active substance iohexol.

Lot No. C2 relates to the partial lot 2. In this subject Lot only contrast agents with the active ingredient iohexol and an iodine concentration of 300mg / ml are in demand.


V08AB02 - iohexol - partless 3

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

According to the different iodine concentrations, a total of three partial lots are formed for the active substance iohexol.

Lot No. C3 relates to the partial lot 3. In this subject Lot only contrast agents with the active ingredient Iohexol and an iodine concentration of 350mg / ml are in demand.


V08AB04 - Iopamidol - partial 1

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

According to the different iodine concentrations, a total of three partial lots are formed for the active substance iopamidol.

Lot No. D1 relates to the partial lot 1. In this subject lot only contrast agents with the active ingredient Iopamidol and iodine concentrations of 200 mg / ml and 250 mg / ml are in demand.


V08AB04 - Iopamidol - partial 2

Reference is made to the brief description of the subject-matter of the contract (see point II.1.4) and, in particular, to the following:

According to the different iodine concentrations, a total of three partial lots are formed for the active substance iopamidol.

Lot No. D2 concerns Teillos 2. In this Fachlos only contrast agents with the active substance iopamidol and an iodine concentration of 300 mg / ml are in demand.

Download full details as .pdf
The Buyer:
AOK Baden-Württemberg
CPV Code(s):
33600000 - Pharmaceutical products
33696000 - Reagents and contrast media